Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination

NCT02425241 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: pSG2.HIVconsv DNA vaccine
BIOLOGICAL: ChAdV63.HIVconsv booster vaccine
BIOLOGICAL: MVA.HIVconsv booster vaccine
DRUG: CPHPC
OTHER: Placebo

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]